OUR COMPANY
We are an A*STAR spin-off focused on future-relevant solutions in this new era of regenerative science.
THE CELLIGENICS STORY
Celligenics is a biotechnology company specialised in the development of future-relevant solutions using breakthrough stem cell technology.
We believe that we have the means to empower humanity by unlocking a new generation of lifesaving and life-enhancing products – for healthcare, beauty and beyond.
Collectively, our core expertise spans across investment finance, enterprise strategy and product development, as well as experience in the field of working with molecular and cell biology.
OUR CORE VALUES
To Serve With A Commitment -
to professionalism, integrity
& passion
OUR MISSION
To Be A Leader -
in the innovative isolation & application of human stem cells & deliverables
OUR VISION
To Empower People -
with regenerative healthcare solutions that will enhance the quality of human life
OUR CORE
STRENGTHS
Diversified biotechnology company engaged in multiple inter-related businesses, allowing a synergistic effect.
Ownership of several patents and licences, with some ready to commence clinical trials.
Major emphasis on research & development as a core of the company's enterprise strategy.
Strategic partnerships with established companies and reputable research and academic institutions.
Experienced management team with strong credentials in the dual-facet of enterprise management and scientific research.
BOARD OF DIRECTORS
HUANG BAN CHIN
Director
Celligenics
Chief Operating Officer
Best World International
KOH CHOON HUI
Board Advisor
Celligenics
Former Chairman
Singapore Pools
Former Managing Director
Roche Singapore
KURT WEE
Director
Celligenics
President
Association of Small & Medium Enterprises
Chairman
Singapore Business Federation SME Committee
SPECIAL ADVISORY BOARD
AMITTHA WICKREMA, Ph.D
UNIVERSITY OF CHICAGO
Professor
Haematology & Oncology
(University of Chicago)
Director
Clinical Cell Therapy Laboratory
(University of Chicago Hospital)
CORE TEAM
KURT WEE
Chief Executive Officer
PAMELA MOK
Director, Regenerative Technology
TBA
